Management of severely painful uterine leiomyoma in a pregnant woman with epidural block using a subcutaneous injection port

2014 ◽  
Vol 93 (8) ◽  
pp. 839-839 ◽  
Author(s):  
So-Young Kwon ◽  
Guisera Lee ◽  
Yong-Shin Kim
Keyword(s):  
Pregnant Woman ◽  
Subcutaneous Injection ◽  
Uterine Leiomyoma ◽  
Epidural Block ◽  
Injection Port

Indwelling intrathecal catheter with subcutaneous abdominal reservoir: a viable baclofen delivery system in severely cachectic patients

2014 ◽  
Vol 14 (4) ◽  
pp. 409-413 ◽  
Author(s):  
Mueez Waqar ◽  
Jonathan R. Ellenbogen ◽  
Ram Kumar ◽  
Christine Sneade ◽  
Bassel Zebian ◽  
...  
Keyword(s):  
Subcutaneous Injection ◽  
Surgical Intervention ◽  
Muscle Tone ◽  
Subcutaneous Fat ◽  
Intrathecal Baclofen ◽  
Injection Port ◽  
Intrathecal Catheter ◽  
Classical Procedure ◽  
Alternative Approach ◽  
Port System

Intrathecal baclofen (ITB) is a reversible treatment that reduces muscle tone to ameliorate spasticity and dystonia in patients with cerebral palsy (CP). The resulting decrease in energy expenditure allows patients to gain much-needed weight, albeit temporarily. Modern techniques require sufficient abdominal musculature and subcutaneous fat to permit the implantation of an indwelling pump. In patients with extremely low muscle bulk, visceral pumps may be impractical or impossible, with increased risks of dehiscence and infection. The authors describe a variation of the classical procedure in a young patient with severe cachexia. A 10-year-old boy with spastic-dystonic quadriplegic CP was admitted to the neuromedical unit. Numerous drug trials had failed, and surgical intervention was deemed necessary but was complicated by his cachectic body habitus. The authors inserted a lumbar intrathecal catheter and subcutaneously tunneled it to the anterolateral abdomen, where it was connected to a subcutaneous injection port. Baclofen was continuously infused into the subcutaneous port using a noncoring needle connected to an external pump. The needle and line were changed every 5 days to minimize the risk of sepsis. Although other techniques, such as intraventricular baclofen delivery, have been described, these are largely dependent upon sufficient musculature to support a visceral pump. A subcutaneous injection port system represents an alternative approach that reduces the risk of sepsis and may be better tolerated in cachectic patients.

Use of a subcutaneous injection port to improve glycemic control in children with type 1 diabetes

2009 ◽  
Vol 10 (2) ◽  
pp. 116-119 ◽  
Author(s):  
Patricia Burdick ◽  
Sonia Cooper ◽  
Brian Horner ◽  
Erin Cobry ◽  
Kim McFann ◽  
...  
Keyword(s):  
Type 1 Diabetes ◽  
Glycemic Control ◽  
Subcutaneous Injection ◽  
Injection Port

The subcutaneous injection port: a new chest-wall artifact.

Radiology ◽  
1985 ◽  
Vol 154 (1) ◽  
pp. 246-246 ◽  
Author(s):  
C S Marn ◽  
S R Luck ◽  
A K Poznanski
Keyword(s):  
Chest Wall ◽  
Subcutaneous Injection ◽  
Injection Port
Sign in / Sign up

Export Citation Format

Share Document